- Home
- REAL vs ZLAB Comparison
REAL vs ZLAB Comparison
Compare REAL & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REAL | ZLAB |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | REAL | ZLAB |
|---|---|---|
| Price | $11.69 | $21.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $17.00 | ★ $49.60 |
| AVG Volume (30 Days) | ★ 2.4M | 611.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.55 | 38.46 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $692,845,000.00 | $460,156,000.00 |
| Revenue This Year | $14.30 | $9.75 |
| Revenue Next Year | $10.15 | $26.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 15.38 | 15.33 |
| 52 Week Low | $4.71 | $15.96 |
| 52 Week High | $17.39 | $44.34 |
Technical Indicators
Market Signals| Indicator | REAL | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 50.64 |
| Support Level | $10.52 | $16.88 |
| Resistance Level | $12.87 | $25.28 |
| Average True Range (ATR) | 0.67 | 0.87 |
| MACD | 0.06 | -0.30 |
| Stochastic Oscillator | 52.14 | 21.19 |
Price Performance
Historical ComparisonAbout REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.